United States· US:69489-212_e5d4b4fa-1951-4fa8-9677-acb97b10c087
ZILXI
A minocycline product containing minocycline hydrochloride, registered in United States by Journey Medical Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MINOCYCLINE HYDROCHLORIDE
- Manufacturer
- Journey Medical Corporation
- Country
- United States (US)
- ATC code
- D10AF07
- ATC class
- Minocycline
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1169489212031 CAN in 1 CARTON (69489-212-03) / 3 g in 1 CAN
- ndc1169489212301 CAN in 1 CARTON (69489-212-30) / 30 g in 1 CAN
- ndc1169489-212-03
- ndc1169489-212-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for minocycline.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Minocycline · interactions on record
4 records
- 1 severe
- 3 moderate
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Porfimer sodiumL01XD01moderate
- MethoxsalenL01XD10moderate
- VerteporfinS01LA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Minocycline in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAcnamino MR 100mg capsulesAlmus Pharmaceuticals Ltd
- BelgiumKlinotab 100 mgTeofarma
- NorwayMinocinTeofarma
- NetherlandsMinocycline Aurobindo 100 mg, omhulde tablettenAurobindo Pharma B.V.
- CanadaARESTIN MICROSPHERESORA PHARMA INC.
- GermanyMinoplusChephasaar Chemisch-Pharmazeutische Fabrik Gmbh
- IrelandMinocin SA 100 mg Modified Release CapsulesViatris Healthcare Limited
- FranceMYNOCINE 100 mg, géluleLABORATOIRE XO
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Minostad
- Belgium · Klinotab, Mino-50
- Bulgaria · Миноциклин Екофарм
- Cyprus · Minaxen
- Germany · Minoplus, Skid
- Spain · Minocin Vía Oral
- France · Kyno, Mynocine
- United Kingdom (Northern Ireland) · Dentomycin, Minocin Mr
- Greece · Minocin
- Ireland · Minocin Sa, Minosil
- Italy · Minocin
- Luxembourg · Klinotab, Mino
- Malta · Minaxen
- Netherlands · Minocycline Eurogenerics, Minocycline Hydrochloride Dihydrate Aurobindo
- Portugal · Cipancin, Minocin
- Romania · Minoz Ep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b35f7f23-e14a-4f14-94e7-e0c9a051c130 GET /v1/drugs/b35f7f23-e14a-4f14-94e7-e0c9a051c130?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "15",
"substance": "MINOCYCLINE HYDROCHLORIDE",
"productndc": "69489-212",
"dosage_form": "AEROSOL, FOAM",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": "NDA213690",
"marketing_category": "NDA"
}See everything about minocycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.